Questionnaire for Metabolic Screening

Overview

The purpose of this study is to determine if kidney stone patients who should have received metabolic tests (urine collection over 24-hours that determines the composition of urine) based on Canadian Urologic Association (CUA) guidelines did in fact receive them, and if these results were explained to them by their doctor.

Full Title of Study: “Use of Metabolic Evaluations for Patients With Renal Calculi and the Risk of Recurrence”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: October 1, 2023

Detailed Description

PURPOSE: The purpose of the project is to determine whether metabolic workups are administered to Canadian kidney stone patients in accordance to CUA (Canadian Urologic Association) guidelines. Additionally, the study will look to evaluate whether the results of metabolic tests were sufficiently explained to patients by their doctors, and also whether or not patients would follow dietary or treatment plans to possibly prevent kidney stones based on these metabolic workups. HYPOTHESIS: The investigators hypothesize that the implementation of metabolic tests based on CUA guidelines is sub-optimal and that when they are prescribed, doctors do not adequately explain these results to patients. The investigators also hypothesize that patients would follow dietary and treatment plants to prevent recurrent stone formation based on these metabolic results – if they are prescribed to the patient. JUSTIFICATION: The investigators believe that implementation of metabolic workups is sub-optimal. The investigators would like to confirm this so that, in the future, metabolic workups can be promoted as an appropriate tool for identifying metabolic abnormalities that contribute to stone disease. If metabolic workups are administered and explained adequately to patients then further diet or treatment plans can significantly reduce recurrence of stones in stone patients. OBJECTIVES: 1. Determine if metabolic workups were administered when they should have been according to CUA guidelines. 2. For patients who received metabolic workups, determine if the results from metabolic workups were explained to patients, and if so was it done adequately (did the patient understand the explanation) 3. Determine patient compliance regarding dietary and treatment plans based on metabolic workups RESEARCH DESIGN: This is a survey based study (one time completion) given to patients pre-ESWL. The surveys will be analyzed by research staff to determine the study objectives.

Clinical Trial Outcome Measures

Primary Measures

  • Metabolic Evaluation
    • Time Frame: through study completion – an average of 10 months
    • Number of participants that did not receive metabolic evaluations based on Canadian Urologic Association (CUA) criteria

Secondary Measures

  • Doctor Patient Communication
    • Time Frame: at the end of study completion – an average of 10 months
    • Number of Participants that received metabolic evaluations but did not have the results adequately explained to them
  • Patient Dietary/Treatment Compliance
    • Time Frame: at the end of study completion – an average of 10 months
    • Number of patients willing to comply with dietary/treatment advice based on the results of the metabolic evaluations

Participating in This Clinical Trial

Inclusion Criteria

  • at least 19 years of age, with at least 1 stone episode, ability to consent Exclusion Criteria:

  • inability to provide informed consent, under 19 years of age

Gender Eligibility: All

Minimum Age: 19 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of British Columbia
  • Collaborator
    • Université de Montréal
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ben Chew, MD, Associate Professor – University of British Columbia
  • Overall Official(s)
    • Nhaeem Bhojani, MD, Principal Investigator, Université de Montréal
    • Ben H Chew, MD, Principal Investigator, University of British Columbia
  • Overall Contact(s)
    • Nhaeem Bhojani, MD, 514-861-0213, naeem.bhojani.chum@ssss.gouv.qc.ca

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.